Nanoparticle-mediated targeted protein degradation (NanoTPD): Principles, rational design and mechanisms of degradation

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Nano Today

• Publication date

  2026-02-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.nantod.2025.102926
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor microenvironment responsive nano-PROTAC for BRD4 degradation enhanced cancer photo-immunotherapy.

  2025cited by this paper
• Nanoparticle‐Mediated Targeted Protein Degradation: An Emerging Therapeutics Technology

  2025cited by this paper
• Targeted protein degradation for cancer therapy

  2025cited by this paper
• Advancements in delivery Systems for Proteolysis-Targeting Chimeras (PROTACs): Overcoming challenges and expanding biomedical applications.

  2025cited by this paper
• Effervescent Microneedles for the Codelivery of Chitosan Nanoparticles and Indocyanine Green To Enhance the Treatment of Diet-Induced Obesity in Mice.

  2025cited by this paper
• Multivalent RGD Peptide-Mediated Nanochimera for Lysosomal Degradation of PDL1 Protein.

  2025cited by this paper
• Development of a nano-targeting chimera for the degradation of membrane and cytoplasmic proteins.

  2025cited by this paper
• Autophagy-Activating Nanoautophagosome-Tethering Compounds for Targeted Protein Degradation Specifically in Tumor Cells.

  2025cited by this paper
• A Bifunctional Lysosome‐Targeting Chimera Nanoplatform for Tumor‐Selective Protein Degradation and Enhanced Cancer Immunotherapy

  2025cited by this paper
• Research Advances in Chaperone-Mediated Autophagy (CMA) and CMA-Based Protein Degraders.

  2025cited by this paper
• Modular Nanoassemblies Mimicking p62 Aggregates for Targeted Organelle Sequestration and Degradation against Breast Cancer.

  2025cited by this paper
• Anti-PEG Antibodies and Their Biological Impact on PEGylated Drugs: Challenges and Strategies for Optimization

  2025cited by this paper
• Unconventional PROTACs for cancer therapy.

  2025cited by this paper
• Nanoinducer-mediated mitochondria-selective degradation enhances T cell immunotherapy against multiple cancers

  2025cited by this paper
• Leveraging chemotherapy-induced PD-L1 upregulation to potentiate targeted PD-L1 degradation using nanoparticle-based targeting chimeras

  2024cited by this paper
• Targeted protein degradation: current molecular targets, localization, and strategies.

  2024cited by this paper
• A plug-and-play monofunctional platform for targeted degradation of extracellular proteins and vesicles

  2024cited by this paper
• Targeted degradation of membrane and extracellular proteins with LYTACs

  2024cited by this paper
• A Review: Surface Engineering of Lipid-Based Drug Delivery Systems.

  2024cited by this paper
• Supramolecular artificial Nano-AUTACs enable tumor-specific metabolism protein degradation for synergistic immunotherapy

  2024cited by this paper
• Light‐Triggered PROTAC Nanoassemblies for Photodynamic IDO Proteolysis in Cancer Immunotherapy

  2024cited by this paper
• Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy

  2024cited by this paper
• New-generation advanced PROTACs as potential therapeutic agents in cancer therapy

  2024cited by this paper
• Targeted protein degradation: from mechanisms to clinic

  2024cited by this paper
• Pooled multicolour tagging for visualizing subcellular protein dynamics

  2024cited by this paper
• Biomimetic Nano‐Degrader Based CD47‐SIRPα Immune Checkpoint Inhibition Promotes Macrophage Efferocytosis for Cardiac Repair

  2024cited by this paper
• A co-assembly platform engaging macrophage scavenger receptor A for lysosome-targeting protein degradation

  2024cited by this paper
• Targeted protein degradation directly engaging lysosomes or proteasomes.

  2024cited by this paper
• Ubiquitin in autophagy and non-protein ubiquitination

  2024cited by this paper
• A PROTAC Augmenter for Photo‐Driven Pyroptosis in Breast Cancer

  2024cited by this paper
• Nano-PROTACs: state of the art and perspectives.

  2024cited by this paper
• Chemotherapy‐Enabled Colorectal Cancer Immunotherapy of Self‐Delivery Nano‐PROTACs by Inhibiting Tumor Glycolysis and Avoiding Adaptive Immune Resistance

  2024cited by this paper
• Nanoreceptors promote mutant p53 protein degradation by mimicking selective autophagy receptors

  2024cited by this paper
• From PROTAC to TPD: Advances and Opportunities in Targeted Protein Degradation

  2024cited by this paper
• Strategy and Design of In Situ Activated Protein Hydrolysis Targeted Chimeras.

  2024cited by this paper
• Recent advances in developing targeted protein degraders.

  2024cited by this paper
• In Vivo Self-Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy.

  2024cited by this paper
• A Self-Assembled Nano-Molecular Glue (Nano-mGlu) Enables GSH/H2O2-Triggered Targeted Protein Degradation in Cancer Therapy.

  2024cited by this paper
• Lysosome‐Targeting Protein Degradation Through Endocytosis Pathway Triggered by Polyvalent Nano‐Chimera for AD Therapy

  2024cited by this paper
• Nanotechnology-Enabled Targeted Protein Degradation for Cancer Therapeutics.

  2024cited by this paper
• Sonodynamic Nano-LYTACs Reverse Tumor Immunosuppressive Microenvironment for Cancer Immunotherapy.

  2024cited by this paper
• Targeted protein degradation: advances in drug discovery and clinical practice

  2024cited by this paper
• Targeted protein degradation via cellular trafficking of nanoparticles

  2024cited by this paper
• Intelligent Modular DNA Lysosome-Targeting Chimera Nanodevice for Precision Tumor Therapy.

  2024cited by this paper
• Sequential responsive nano-PROTACs for precise intracellular delivery and enhanced degradation efficacy in colorectal cancer therapy

  2024cited by this paper
• Adverse Impacts of PEGylated Protein Therapeutics: A Targeted Literature Review

  2024cited by this paper
• Advancing Proteolysis Targeting Chimera (PROTAC) Nanotechnology in Protein Homeostasis Reprograming for Disease Treatment.

  2024cited by this paper
• Biomarker-activated multifunctional lysosome-targeting chimeras mediated selective degradation of extracellular amyloid fibrils

  2023cited by this paper
• Targeted Degradation of PD-L1 and Activation of the STING Pathway by Carbon-Dot-Based PROTACs for Cancer Immunotherapy.

  2023cited by this paper
• A Physiologically Responsive Nanocomposite Hydrogel for Treatment of Head and Neck Squamous Cell Carcinoma via Proteolysis‐Targeting Chimeras Enhanced Immunotherapy

  2023cited by this paper
• Targeted Protein Degradation Technology and Nanomedicine: Powerful Allies against Cancer.

  2023cited by this paper
• Targeted degradation of ABCG2 for reversing multidrug resistance by hypervalent bispecific gold nanoparticle-anchored aptamer chimeras.

  2023cited by this paper
• Nano‐LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec‐10 Signaling Pathway

  2023cited by this paper
• Aptamer-Based Targeted Protein Degradation.

  2023cited by this paper
• Targeted Biomolecule Regulation Platform: A Split-and-Mix PROTAC Approach.

  2023cited by this paper
• Glutathione‐Scavenging Nanoparticle‐Mediated PROTACs Delivery for Targeted Protein Degradation and Amplified Antitumor Effects

  2023cited by this paper
• Persistent Degradation of HER2 Protein by Hybrid nanoPROTAC for Programmed Cell Death.

  2023cited by this paper
• Apoptotic extracellular vesicle formation via local phosphatidylserine exposure drives efficient cell extrusion.

  2023cited by this paper
• Self-Assembled Nano-PROTAC Enables Near-Infrared Photodynamic Proteolysis for Cancer Therapy.

  2023cited by this paper
• Nano Proteolysis Targeting Chimeras (PROTACs) with Anti-Hook Effect for Tumor Therapy.

  2023cited by this paper
• DNA framework-engineered chimeras platform enables selectively targeted protein degradation

  2023cited by this paper
• Logic Gate Activated Lysosome Targeting DNA Nanodevice for Controlled Proteins Degradation

  2023cited by this paper
• Targeted degradation of extracellular secreted and membrane proteins.

  2023cited by this paper
• Targeted Protein Degradation Mediated by Genetically Engineered Lysosome-Targeting Exosomes.

  2023cited by this paper
• Recent progress in degradation of membrane proteins by PROTACs and alternative targeted protein degradation techniques.

  2023cited by this paper
• Covalent LYTAC Enabled by DNA Aptamers for Immune Checkpoint Degradation Therapy.

  2023cited by this paper
• Extracellular targeted protein degradation: an emerging modality for drug discovery

  2023cited by this paper
• Targeted Degradation of Signal Transduction and Activator of Transcription 3 by Chaperone-Mediated Autophagy Targeting Chimeric Nanoplatform.

  2023cited by this paper
• The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system

  2022cited by this paper
• Extracellular matrix physical properties govern the diffusion of nanoparticles in tumor microenvironment

  2022cited by this paper
• Checkpoint Nano‐PROTACs for Activatable Cancer Photo‐Immunotherapy

  2022cited by this paper
• Recent Advances of Degradation Technologies Based on PROTAC Mechanism

  2022cited by this paper
• Versatile Nano‐PROTAC‐Induced Epigenetic Reader Degradation for Efficient Lung Cancer Therapy

  2022cited by this paper
• Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy

  2022cited by this paper
• Chasing molecular glue degraders: screening approaches.

  2022cited by this paper
• Targeted protein degradation: mechanisms, strategies and application

  2022cited by this paper
• 2d-Protacs with Augmented Protein Degradation for Super-Resolution Photothermal Optical Coherence Tomography Guided Momentary Multimodal Therapy

  2022cited by this paper
• E3 ubiquitin ligases: styles, structures and functions

  2021cited by this paper
• Smart Nano-PROTACs Reprogram Tumor Microenvironment for Activatable Photo-metabolic Cancer Immunotherapy.

  2021cited by this paper
• Multicompartment systems: a putative carrier for combined drug delivery and targeting.

  2021cited by this paper
• Redefining the Scope of Targeted Protein Degradation: Translational Opportunities in Hijacking the Autophagy-Lysosome Pathway.

  2021cited by this paper
• Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins

  2021cited by this paper
• Covalently Engineered Nanobody Chimeras for Targeted Membrane Protein Degradation.

  2021cited by this paper
• A structure-based engineering approach to abrogate pre-existing antibody binding to biotherapeutics

  2021cited by this paper
• Degradation of lipid droplets by chimeric autophagy-tethering compounds

  2021cited by this paper
• Targeting autophagy in disease: established and new strategies

  2021cited by this paper
• PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application

  2021cited by this paper
• A nano-predator of pathological MDMX construct by clearable supramolecular gold(I)-thiol-peptide complexes achieves safe and potent anti-tumor activity

  2021cited by this paper
• Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy

  2021cited by this paper
• From Conception to Development: Investigating PROTACs Features for Improved Cell Permeability and Successful Protein Degradation

  2021cited by this paper
• LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation

  2021cited by this paper
• Target Reprogramming Lysosomes of CD8+ T Cells by a Mineralized Metal–Organic Framework for Cancer Immunotherapy

  2021cited by this paper
• Development of Triantennary N-Acetylgalactosamine Conjugates as Degraders for Extracellular Proteins

  2020cited by this paper
• Lysosome-targeting chimaeras for degradation of extracellular proteins

  2020cited by this paper
• Prey for the Proteasome: Targeted Protein Degradation—A Medicinal Chemist's Perspective

  2020cited by this paper
• Emerging New Concepts of Degrader Technologies

  2020cited by this paper
• Protein labeling approach to improve lysosomal targeting and efficacy of antibody-drug conjugates.

  2020cited by this paper
• Targeted degradation of anaplastic lymphoma kinase by gold nanoparticle-based multi-headed proteolysis targeting chimeras.

  2020cited by this paper
• Strategies for Delivering Nanoparticles across Tumor Blood Vessels

  2020cited by this paper
• Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy

  2020cited by this paper

• No citing papers are available for this paper.